U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. 2022 Center for Biologics Evaluation and Research (CBER) Science Symposium - 09/20/2022
  1. News & Events

Symposium | Virtual

Event Title
2022 Center for Biologics Evaluation and Research (CBER) Science Symposium
September 20 - 22, 2022

Scheduled
Date:
September 20 - 22, 2022

PURPOSE OF PUBLIC WORKSHOP

The purpose of the public symposium is to discuss scientific topics related to the regulation of biologics and highlight science conducted at CBER by showcasing how scientific research informs regulatory decision making, and to provide a forum for developing collaborations within FDA and with external organizations. The symposium will include presentations by experts from academic institutions, government agencies and research institutions.

SUPPLEMENTARY INFORMATION

Topics for Discussion

The public symposium will include presentations on the following topics: (1) advanced manufacturing and analytics; (2) advances in computational science supporting biologics’ evaluation; (3) biomarker discovery; (4) immune responses to vaccination; (5) genome therapy including gene editing; and (6) emerging and re-emerging diseases.

REGISTRATION

Persons interested in attending this public symposium must register online at https://www.eventbrite.com/e/2022-cber-science-symposium-tickets-394637380027. This public symposium will be held virtually only. Webcast information/link will be provided upon completion of registration.

If you need special accommodations due to a disability, please contact Loni Warren Henderson or Irene Carroll no later than September 6, 2022 at CBERPublicEvents@fda.hhs.gov (subject line: 2022 CBER Science Symposium).

MEETING AGENDA

Center for Biologics Evaluation and Research (CBER) 2022 Science Symposium 2022 Science Symposium Meeting Agenda

Recordings

FOR FURTHER INFORMATION CONTACT:

Loni Warren Henderson or Irene Carroll, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 1118, Silver Spring, MD 20993, 240-402-8010, CBERPublicEvents@fda.hhs.gov (subject line: 2022 CBER Science Symposium).

Back to Top